The Food and Drug Administration has approved a new implantable device to help doctors monitor patients with severe heart failure as they go about their day.
Nine scientists won awards Thursday for theories about the first moments of the universe, discoveries about the brain and techniques to let researchers see ever-tinier things.
Doctors in Italy have designed a miniature dialysis machine for babies, used for the first time last year to save a newborn girl, according to a new report.
Medtronic has agreed to pay more than $1 billion to settle long-standing patent litigation with fellow medical device maker Edwards Lifesciences over replacement heart valves.
Britain is offering almost $17 million to whoever can solve one of humanity's biggest scientific challenges — once the public has decided what it is.
Germany's Bayer AG says it's selling its interventional division to the Boston Scientific Corporation for $415 million so that it can focus on growth in other areas.
Suman traveled to New York to tape the show's regular segment called "Fallonventions," which showcases the achievements of young inventors. He used his Steth IO, which turns a smartphone into a stethoscope, to listen to Fallon's heart.
Medical device maker Boston Scientific said Thursday the U.S. government wants documents related to its Cognis and Teligen heart devices.
Scientists implanted thin sheets of scaffolding-like material from pigs into a few young men with disabling leg injuries — and say the experimental treatment coaxed the men's own stem cells to regrow new muscle.
Drug and medical device maker says it will pay $830 million to resolve roughly 20,000 personal lawsuits from patients who say they were injured by the company's vaginal mesh implants.
Makers of trouble-prone implants used to surgically repair women's pelvic problems would be subject to stricter safety requirements under a federal proposal issued Tuesday.
The artificial implant in Pontz's left eye is part of a system developed by Second Sight that includes a small video camera and transmitter housed in a pair of glasses.
Questions of affordability, eligibility, immigrant access and the response from employers and state legislatures — obstacles that existed before the Affordable Care Act took effect — mean considerable work remains to make a larger dent in the uninsured population.
It is an ambitious project to first, make a heart and then get it to work in a patient, and it could be years — perhaps decades — before a 3-D printed heart would ever be put in a person.
When the implanted device is activated, the men can wiggle their toes, lift their legs and stand briefly. But they aren't able to walk and still use wheelchairs to get around.
While only a handful of patients have received the British lab-made organs so far, researchers hope they will soon be able to transplant more types of body parts into patients, including what would be the world's first nose made partly from stem cells.
The nation's disease detectives are beginning a program to try to outsmart outbreaks by routinely decoding the DNA of potentially deadly bacteria and viruses.
Scientists have created a detailed, three-dimensional wiring diagram of the mouse brain. That should help researchers seek clues about how the human brain works in health and disease.
Johnson & Johnson has accepted an offer of about $4 billion from the private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics business.
Survival rates were better one year later for people who had a new valve placed through a tube into an artery instead.
Lawyers and advocates for women alleging Johnson & Johnson products injured them urged the U.S. Justice Department on Wednesday to investigate their claims the health care giant deliberately destroyed many documents critical to their lawsuits.
Dr. Glenn Green and Scott Hollister came up with the solution to save a young boy's life: use 3D printing to build small splints that would help keep his trachea open until it was strong enough to do so itself.
IBM and its Watson cloud computing system are partnering with the New York Genome Center to help it sequence DNA for the treatment of brain cancer.
Renal services provider Fresenius Medical Care has announced it will locate its East Coast manufacturing facility in Knoxville, creating 665 jobs in the coming years.